INVO BioScience, Inc. (INVO) Financials
Stock symbol INVO is outdated, potentially delisted? Maybe it is available on other exchange?
INVO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 19.5 million | 19.1 million |
| June 30, 2023 | 6.6 million | 8.3 million |
| March 31, 2023 | 4.1 million | 5.1 million |
| Dec. 31, 2022 | 4.1 million | 5.1 million |
INVO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -1.4 million | 265473 |
| June 30, 2023 | -1.9 million | 426254 |
| March 31, 2023 | -1.0 million | 412199 |
| Dec. 31, 2022 | -1.0 million | 412199 |
INVO Net Income
No data available :(
INVO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 1.1 million | - | 6.0 million |
| June 30, 2023 | 112485 | - | 4.1 million |
| March 31, 2023 | 90135 | - | 1.8 million |
| Dec. 31, 2022 | - | - | 1.9 million |
INVO Shares Outstanding
INVO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | 108217 | 2668 | 1.3 million | - |
| June 30, 2023 | 261505 | 83850 | 2.0 million | - |
| March 31, 2023 | 135 | 73835 | 2.5 million | - |
| Dec. 31, 2022 | 135 | 73835 | 2.8 million | - |
INVO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | 974894 | 580968 |
| June 30, 2023 | 315902 | 255419 |
| March 31, 2023 | 278142 | 79194 |
| Dec. 31, 2022 | 278142 | 79194 |
INVO
Price: $0.83
52 week price:
Earnings Per Share: 0.69 USD
P/E Ratio: 1.01
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 111179
Market Capitalization: 2.7 million